In our study, in the early stages of breast cancer and in fibroadenomas, the level of IL-8 reaches its maximum values; in the transition to advanced stages, the observed decrease characterizes a more pronounced immune response in early breast cancer. This evidence concerns the gene CXCL8 and breast carcinoma.